Merck KGaA - Price Target for Depositary Receipt (MKKGY) Reduced by 14.67% to 62.85

Written by Emily J. Thompson, Senior Investment Analyst

Source: NASDAQ.COM

Updated: Oct 29 2025

0mins

Source: NASDAQ.COM

Revised Price Target: The average one-year price target for Merck KGaA - Depositary Receipt (OTCPK:MKKGY) has been lowered to $62.85 per share, a 14.67% decrease from the previous estimate of $73.65.
Analyst Targets: Current analyst targets for MKKGY range from a low of $10.03 to a high of $118.15 per share, indicating a potential increase of 68.99% from the latest closing price of $37.19.
Fund Sentiment: There are 12 funds reporting positions in MKKGY, with an average portfolio weight of 0.19%, which has increased by 1.50%. Institutional ownership rose by 8.92% over the last three months.
Shareholder Activity: Notable changes in shareholder positions include significant increases by APIE and ACIFX, while Rhumbline Advisers reduced their holdings by 8.16%.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

GET FREE REAL TIME NOTIFICATIONS

Stock Monitor for NVDA?

Get Started Free

FREE STOCK RECOMMENDATIONS DAILY

Stock Bullish Tomorrow

Get Started Free

70% BACKTESTED ACCURACY!

Should I Buy NVDA?

Get Started Free